148 related articles for article (PubMed ID: 7315922)
1. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
Soper JT; Creasman WT; Clarke-Pearson DL; Sullivan DC; Vergadoro F; Johnston WW
Am J Obstet Gynecol; 1985 Sep; 153(2):191-6. PubMed ID: 4037013
[TBL] [Abstract][Full Text] [Related]
3. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ
Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy.
Heath R; Rosenman J; Varia M; Walton L
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):815-22. PubMed ID: 3182321
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal cytology in endometrial carcinoma.
Sutton GP
Cancer Treat Res; 1989; 49():41-52. PubMed ID: 2577201
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma.
Szpak CA; Creasman WT; Vollmer RT; Johnston WW
Acta Cytol; 1981; 25(6):640-6. PubMed ID: 6171978
[TBL] [Abstract][Full Text] [Related]
7. Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites.
Bakri YN; Given FT
Am J Obstet Gynecol; 1984 Sep; 150(2):184-8. PubMed ID: 6476040
[TBL] [Abstract][Full Text] [Related]
8. Positive peritoneal cytology in corpus carcinoma. Report of a fatal outcome.
Hacker NF; Castaldok TW; Morrow CP; Ballon SC
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):103-6. PubMed ID: 6958246
[TBL] [Abstract][Full Text] [Related]
9. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology.
Konski A; Poulter C; Keys H; Rubin P; Beecham J; Doane K
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):49-55. PubMed ID: 3335462
[TBL] [Abstract][Full Text] [Related]
10. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
Kadar N; Homesley HD; Malfetano JH
Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM
Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Soper JT; Berchuck A; Clarke-Pearson DL
Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
[TBL] [Abstract][Full Text] [Related]
13. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.
Creasman WT; Morrow CP; Bundy BN; Homesley HD; Graham JE; Heller PB
Cancer; 1987 Oct; 60(8 Suppl):2035-41. PubMed ID: 3652025
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus.
Obermair A; Geramou M; Tripcony L; Nicklin JL; Perrin L; Crandon AJ
Cancer Lett; 2001 Mar; 164(1):105-10. PubMed ID: 11166922
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cytologic peritoneal washings.
Willett GD
Clin Lab Med; 1985 Jun; 5(2):265-74. PubMed ID: 3896625
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Powell JL; Burrell MO; Kirchner AB
South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895
[TBL] [Abstract][Full Text] [Related]
18. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer.
Yazigi R; Piver MS; Blumenson L
Obstet Gynecol; 1983 Sep; 62(3):359-62. PubMed ID: 6877692
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal cytology in endometrial cancer: a review.
McLellan R; Dillon MB; Currie JL; Rosenshein NB
Obstet Gynecol Surv; 1989 Oct; 44(10):711-9. PubMed ID: 2677857
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma.
Eltabbakh GH; Mount SL
Gynecol Oncol; 2006 Feb; 100(2):361-4. PubMed ID: 16185754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
